| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 17.69B | 18.38B | 19.85B | 21.66B | 18.45B |
| Gross Profit | 5.78B | 18.38B | 19.85B | 21.66B | 18.45B |
| EBITDA | 8.02B | 6.79B | 7.28B | 5.84B | 6.04B |
| Net Income | 3.24B | 2.90B | 2.29B | 7.80B | 2.35B |
Balance Sheet | |||||
| Total Assets | 108.28B | 106.74B | 98.33B | 92.70B | 94.86B |
| Cash, Cash Equivalents and Short-Term Investments | 2.83B | 6.93B | 4.25B | 2.77B | 3.35B |
| Total Debt | 46.76B | 48.36B | 47.07B | 42.98B | 45.47B |
| Total Liabilities | 68.95B | 68.92B | 68.43B | 63.13B | 71.00B |
| Stockholders Equity | 39.30B | 37.80B | 29.87B | 29.54B | 23.83B |
Cash Flow | |||||
| Free Cash Flow | -3.76B | -2.50B | -514.00M | 6.00M | 728.00M |
| Operating Cash Flow | 6.23B | 6.81B | 6.94B | 6.90B | 6.27B |
| Investing Cash Flow | -4.49B | -10.57B | -7.50B | 240.00M | -14.01B |
| Financing Cash Flow | -2.69B | 4.53B | 987.00M | -7.17B | 7.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
62 Neutral | £59.48B | 18.35 | 8.47% | 4.15% | -3.76% | 8.19% | |
59 Neutral | £28.10B | 23.26 | 7.09% | 2.98% | 0.54% | -5.54% | |
59 Neutral | £8.49B | 40.40 | 1.68% | 2.86% | -2.11% | -104.48% | |
58 Neutral | £9.98B | 15.62 | 27.72% | 4.45% | 21.96% | 121.69% | |
55 Neutral | £8.94B | 24.11 | 20.35% | 4.50% | 16.66% | 61.14% |